KRAS, one of the three RAS isoforms (KRAS, HRAS, NRAS), is the most frequently mutated RAS protein in cancer patients, and G12, G13, and Q61 are three hot spots among the oncogenic mutations. This evidence concerns the gene KRAS and cancer.